About
Technology
Issues
FAQ
Links
Official Page
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.